See every side of every news story
Published loading...Updated

Gencor’s PEA shows pain-reducing effects against acute menstrual cramping

Summary by nutraingredients.com
Gencor’s palmitoylethanolamide (PEA) ingredient, Levagen+, has shown significant pain-reducing effects against acute menstrual cramps in a clinical study, demonstrating a 25% greater reduction in pain compared to a placebo within 2.5 hours of a single dose. The study suggests that PEA could be a natural, effective alternative to NSAIDs.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

nutraingredients.com broke the news in on Friday, February 14, 2025.
Sources are mostly out of (0)